FDA approves Xolair prefilled syringe for self-injection across all indications – Genentech + Novartis
Genentech, a member of the Roche Group announced that the FDA has approved the company’s supplemental Biologics License Application for Xolair (omalizumab) prefilled syringe for self-injection across all… read more.
